Free Trial

Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare logo
$75.70 -0.72 (-0.94%)
As of 10:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, SNN, and BIO

Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estee Lauder Companies (EL), Smith & Nephew SNATS (SNN), and Bio-Rad Laboratories (BIO).

Prestige Consumer Healthcare vs. Its Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Prestige Consumer Healthcare has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.

In the previous week, Interparfums had 3 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 6 mentions for Interparfums and 3 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.78 beat Interparfums' score of 1.26 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prestige Consumer Healthcare
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Interparfums
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prestige Consumer Healthcare$1.14B3.29$214.60M$4.2917.65
Interparfums$1.47B2.90$164.36M$5.1425.73

Prestige Consumer Healthcare has a net margin of 18.86% compared to Interparfums' net margin of 11.30%. Interparfums' return on equity of 17.62% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare18.86% 12.87% 6.78%
Interparfums 11.30%17.62%11.86%

Prestige Consumer Healthcare presently has a consensus target price of $93.33, suggesting a potential upside of 23.30%. Interparfums has a consensus target price of $162.00, suggesting a potential upside of 22.51%. Given Prestige Consumer Healthcare's higher probable upside, equities research analysts plainly believe Prestige Consumer Healthcare is more favorable than Interparfums.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Interparfums
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.5%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.4%. Prestige Consumer Healthcare pays out 44.3% of its earnings in the form of a dividend. Interparfums pays out 62.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years. Prestige Consumer Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 43.9% of Interparfums shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Interparfums beats Prestige Consumer Healthcare on 11 of the 19 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBH vs. The Competition

MetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.74B$10.24B$5.55B$20.67B
Dividend YieldN/A2.08%5.01%3.72%
P/E Ratio17.6516.9028.4227.48
Price / Sales3.2929.84375.4757.77
Price / Cash14.6723.5224.7317.84
Price / Book2.043.658.234.60
Net Income$214.60M$233.40M$3.21B$991.76M
7 Day Performance-3.88%0.39%3.36%0.20%
1 Month Performance-9.71%5.11%9.36%5.31%
1 Year Performance7.01%-15.80%29.39%9.58%

Prestige Consumer Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBH
Prestige Consumer Healthcare
4.1632 of 5 stars
$75.70
-0.9%
$93.33
+23.3%
+8.7%$3.74B$1.14B17.65540Positive News
IPAR
Interparfums
4.1307 of 5 stars
$136.05
-1.8%
$157.60
+15.8%
+3.3%$4.45B$1.45B26.47530Positive News
HLF
Herbalife
4.4108 of 5 stars
$9.65
-3.3%
$11.50
+19.2%
-10.2%$1.02B$4.95B3.528,600News Coverage
USNA
USANA Health Sciences
4.3377 of 5 stars
$32.14
-1.9%
$36.00
+12.0%
-28.2%$610.28M$854.50M17.661,700Upcoming Earnings
NUS
Nu Skin Enterprises
2.8458 of 5 stars
$8.91
-0.1%
$6.88
-22.8%
-16.7%$440.76M$1.68B-11.143,100Positive News
NATR
Nature's Sunshine Products
1.7035 of 5 stars
$16.02
+2.8%
$18.33
+14.4%
+5.1%$287.84M$454.36M30.23850Positive News
High Trading Volume
MED
Medifast
3.4929 of 5 stars
$14.62
+0.3%
$16.50
+12.9%
-24.1%$160.25M$602.46M-22.49870
VERU
Veru
2.8958 of 5 stars
$0.58
-3.8%
$4.00
+585.4%
-36.2%$88.92M$16.89M-2.43230Positive News
EL
Estee Lauder Companies
4.1077 of 5 stars
$85.82
-3.3%
$74.45
-13.2%
-13.3%$31.92B$15.61B-35.4662,000Positive News
SNN
Smith & Nephew SNATS
3.0392 of 5 stars
$29.95
-1.1%
$28.00
-6.5%
+5.8%$13.26B$5.81B13.8717,349
BIO
Bio-Rad Laboratories
4.6895 of 5 stars
$247.45
-1.6%
$324.25
+31.0%
-17.5%$6.85B$2.54B-3.257,700News Coverage
Analyst Downgrade
Analyst Revision

Related Companies and Tools


This page (NYSE:PBH) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners